DxNA LLC opens Valley Fever multicenter clinical trial

(The Translational Genomics Research Institute) DxNA LLC today announced the start of a multi-center clinical study of DxNA's molecular diagnostic test for the detection of Valley Fever (coccidioidomycosis), using its proprietary diagnostic platform, The GeneSTAT® System. The Valley Fever test has been developed based on intellectual property exclusively licensed from the Phoenix-based non-profit Translational Genetics Research Institute (TGen), and will provide for the rapid detection of the fungus in patients.
Source: EurekAlert! - Medicine and Health - Category: Global & Universal Source Type: news